Filler Types: A Consumer Guide

Key Takeaways

• Hyaluronic acid fillers come in low-cross-linked, monophasic, and biphasic formulations, and the formulation affects how the filler behaves in tissue and how long results may last.
• Calcium hydroxylapatite can be used at full concentration or hyperdiluted, and recent research suggests hybrid CaHA-HA blends may offer additional versatility for certain treatment areas.
• Collagen-crosslinked HA composite fillers are an emerging category studied specifically for delicate zones like the under-eye area, where tissue properties differ from other facial regions.
• PDO microsphere fillers represent a newer option for volume correction that research is beginning to evaluate quantitatively against established fillers.
• No filler is universally 'best'—treatment area, skin quality, desired outcome, and individual anatomy all influence which product a qualified provider may recommend.

What are the main categories of dermal fillers available today?

Dermal fillers fall into four main categories — hyaluronic acid (HA), calcium hydroxylapatite (CaHA), poly-L-lactic acid (PLLA), and polydioxanone (PDO) — each working through a different mechanism and lasting a different length of time. Your choice depends on the treatment area, how much volume or skin-quality improvement you need, and how long you want results to last.

---

Hyaluronic Acid (HA) Fillers

HA fillers dominate the market. They work by attracting and holding water in tissue, adding immediate volume. Manufacturers produce them in two structural formats:

• Monophasic — a single, uniform gel network
• Biphasic — two distinct gel phases combined in one product

A randomized controlled trial comparing both formats for moderate-to-severe nasolabial folds found that both corrected folds effectively, with no clinically meaningful difference in safety between the two types. Cross-linking density matters enormously within the HA category. Low-cross-linked HA spreads more easily through tissue and targets fine surface wrinkles; a six-month clinical study found that low-cross-linked HA improved periorbital and perioral wrinkles and measurably upgraded overall skin quality — not just volume. Highly cross-linked HA holds its shape under mechanical stress and suits deeper structural work. Diluted HA formulations occupy yet another niche: a technique study on infraorbital hollows demonstrated that diluting Belotero Balance and injecting it superficially produced natural-looking correction in a notoriously difficult zone.

---

Calcium Hydroxylapatite (CaHA)

CaHA fillers deliver two effects in sequence: immediate volumizing from the carrier gel, then longer-term collagen stimulation as the body processes the calcium microspheres. Hyperdiluted CaHA — mixed with saline or lidocaine to a thinner consistency — spreads across larger surface areas and acts primarily as a biostimulator rather than a volumizer. A pilot study on stretch marks used hyperdiluted CaHA alongside microneedling radiofrequency and documented measurable tissue improvement. A hybrid CaHA-HA formulation has entered clinical use, combining the structural lift of CaHA with the hydrating properties of HA in a single injection.

---

Poly-L-Lactic Acid (PLLA)

PLLA works slowly. It contains no immediate volumizing gel; the microspheres trigger a gradual collagen-building response over several months. A comprehensive review of minimally invasive facial rejuvenation identifies PLLA as a biostimulator suited to patients seeking progressive, diffuse volume restoration rather than immediate correction.

---

Polydioxanone (PDO) Microsphere Fillers

PDO is best known as a thread-lift material, but PDO microsphere fillers now exist as an injectable option. A comparative quantitative study assessed PDO microsphere fillers for nasolabial fold correction and found measurable improvement, positioning PDO as a biostimulating alternative for patients who want to avoid HA or CaHA.

---

This content is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. Consult a licensed healthcare professional before pursuing any aesthetic procedure.

How do hyaluronic acid filler formulations differ from one another?

Hyaluronic acid fillers are not a single product — manufacturers engineer them with different cross-linking densities, particle sizes, and gel architectures that directly determine where each filler works best, how long it lasts, and what risks it carries. Understanding those differences helps you ask better questions before you sit in the treatment chair.

The core variable is cross-linking: the chemical process that links HA molecules into a stable gel. More cross-linking generally produces a firmer, longer-lasting filler suited to structural work like cheek augmentation; less cross-linking produces a softer gel better suited to fine surface lines or delicate areas. A 2025 randomized controlled trial comparing monophasic and biphasic HA fillers in nasolabial folds found both types corrected folds effectively, but the two architectures behaved differently in tissue integration — a clinically meaningful distinction when your injector is choosing a product.

Key formulation categories and what the evidence says:

• Biphasic fillers contain discrete HA particles suspended in a carrier gel. The particle size and concentration determine lift capacity and longevity. The nasolabial fold RCT confirmed biphasic products remain a reliable benchmark for moderate-to-severe fold correction.

• Monophasic (cohesive) fillers form a single, uniform gel. Softer monophasic products — like Belotero Balance — integrate closely with tissue, making them useful for superficial lines and thin-skinned zones. A clinical study using diluted Belotero Balance for under-eye hollows (source) reported good aesthetic outcomes with a low side-effect profile in that notoriously difficult area.

• Low-cross-linked HA sits at the softest end of the spectrum. It functions less as a volumizer and more as a skin-quality treatment. A six-month study found that low-cross-linked HA injected into periorbital and perioral areas improved wrinkles and measurable skin quality markers — hydration, elasticity — over the follow-up period.

• Composite fillers blend HA with other materials to layer mechanisms. Research on a collagen–cross-linked HA hybrid for under-eye rejuvenation showed the combination supported both immediate volume correction and longer-term tissue remodeling.

Concentration matters too. Injectors sometimes dilute standard fillers intentionally — hyperdilution spreads product over a wider area to improve skin texture rather than add focal volume, a technique increasingly documented across body sites. A comprehensive minimally invasive facial rejuvenation review outlines how product selection and dilution strategy together shape outcomes.

No single formulation is universally superior. The right product depends on anatomy, treatment depth, and the specific correction goal — decisions that require a qualified, experienced injector.

---

This content is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. Consult a licensed healthcare professional before pursuing any aesthetic procedure.

What is calcium hydroxylapatite and how is it used beyond the face?

Calcium hydroxylapatite (CaHA) is a mineral compound — the same one found naturally in human bone — formulated as a gel-suspended microsphere filler that both adds immediate volume and stimulates the body's own collagen production over time. Clinicians inject it into the hands, décolletage, body skin laxity, and intimate areas, extending its use well beyond facial applications.

How it works

CaHA microspheres sit in a gel carrier that provides instant lift. Over the following weeks and months, the body lays down new collagen around those microspheres, which gradually biodegrade. The result is a two-phase effect: structural correction now, biological remodeling later. A comprehensive review of minimally invasive facial rejuvenation techniques (source) identifies this dual mechanism — immediate volumization plus collagen neogenesis — as a defining characteristic that separates CaHA from purely volumizing fillers.

Off-face applications with clinical backing

• Stretch marks (striae distensae). Researchers combined hyperdiluted CaHA injections with fractional microneedling radiofrequency and measured outcomes in a pilot study. That study found meaningful improvement in skin texture and appearance, with the combination outperforming either treatment alone. Stretch marks resist single-modality treatment, making this multimodal approach particularly relevant.

• Labia majora rejuvenation. Volume loss in the labia majora is a documented concern that labiaplasty alone does not address. Clinicians have begun using a hybrid CaHA-plus-hyaluronic-acid filler specifically for this area. A 2025 study on labia majora rejuvenation reported increased patient satisfaction and more uniform results compared with prior approaches, positioning the hybrid formulation as a practical option for patients who want soft-tissue restoration rather than surgical reshaping.

The "hyperdiluted" distinction

When providers use CaHA off-face, they typically dilute it far beyond standard facial concentrations. Thinner. More spreadable. This hyperdiluted form prioritizes skin quality and collagen stimulation over structural volume — a meaningful clinical difference that affects both technique and expected outcome. Body skin behaves differently than facial tissue, which is why the stretch-mark pilot study cited above used this diluted protocol specifically.

What the evidence does not yet show

Long-term durability data for off-face CaHA applications remain limited. Most published work involves small patient groups and short follow-up windows. Results look promising, but anyone considering these treatments should ask their provider directly what the evidence base looks like for their specific area of concern.

---

This content is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. Consult a qualified, licensed healthcare professional before pursuing any aesthetic procedure.

Which fillers are being studied for sensitive areas like under the eyes?

The under-eye area — clinically called the infraorbital region — ranks among the most technically demanding zones for filler treatment. Current research focuses on a small group of specifically engineered hyaluronic acid (HA) products designed to minimize the bluish discoloration known as the Tyndall effect.

Diluted Belotero Balance (low-cohesivity HA)

Belotero Balance is a monophasic HA filler with relatively low cross-linking density, allowing it to integrate into tissue without creating the optical scattering that causes Tyndall effect. Researchers tested a specific delivery method called the "BB8 technique," which involves injecting diluted Belotero Balance across eight precise points in the infraorbital hollow. A 2025 study found this approach produced measurable volume correction with a favorable safety profile in the tear trough — one of the thinnest, most vascular zones on the face.

Low-cross-linked HA for periorbital skin quality

Not all under-eye concerns involve volume loss. Fine lines and skin laxity around the eye respond differently than hollowing does. A clinical study tracked patients over six months after treatment with low-cross-linked HA in the periorbital area and found statistically significant improvements in wrinkle severity and overall skin quality — without the structural lifting that a denser filler would provide. Low cross-linking matters. The product spreads more evenly through superficial tissue rather than sitting as a discrete bolus.

Composite collagen-crosslinked HA

A newer category combines collagen with cross-linked HA in a single formulation. Researchers evaluating this composite filler specifically for infraorbital rejuvenation found it produced both immediate volumizing effects and longer-term improvements in skin texture — suggesting the collagen component may stimulate some degree of tissue remodeling beyond what HA alone achieves.

What is NOT well-studied here

• Calcium hydroxylapatite (CaHA): widely used in other facial zones, but the infraorbital area's thin skin and proximity to the orbital rim make it a higher-risk choice; current research does not support its routine use under the eyes
• Polydioxanone (PDO) microsphere fillers: studied for nasolabial folds (see this comparative study), but peer-reviewed data for infraorbital use remains limited

Soft, low-cohesivity HA products — particularly those with low cross-linking or hybrid collagen formulations — are where active research is concentrated for the under-eye zone.

---

This content is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Consult a licensed healthcare professional before pursuing any aesthetic procedure.

What should consumers ask a provider before choosing a filler treatment?

Before choosing a filler treatment, ask your provider which specific product they plan to use, why that product suits your anatomy and goals, and what the clinical evidence says about how long results last. Those three questions alone will reveal whether you're talking to someone who thinks critically about your care or someone selling a one-size-fits-all menu.

Filler is not a single thing. Hyaluronic acid (HA), calcium hydroxylapatite (CaHA), and polydioxanone (PDO) microspheres each behave differently in tissue, last different lengths of time, and carry different risk profiles. A provider who can't explain that distinction clearly is a red flag.

Questions to ask — and what good answers look like:

• "Which filler formulation will you use, and why this one for my concern?" Monophasic and biphasic HA fillers produce measurably different correction outcomes even in the same treatment area, according to a randomized controlled trial on nasolabial folds. A strong answer names the product, explains its rheology (how it moves and integrates), and connects that directly to your specific anatomy.

• "How long should I realistically expect results to last?" Low-cross-linked HA formulations show measurable improvements in periorbital and perioral skin quality at six months, but results vary by product and placement, as a six-month outcomes study documents. PDO microsphere fillers work through a different mechanism — stimulating collagen rather than adding immediate volume — and comparative research shows their correction trajectory differs from HA. Expect a realistic timeline, not a best-case promise.

• "What technique will you use, and does it match the treatment area?" Technique matters as much as product. Diluted filler delivered with a specialized injection pattern for under-eye hollows, for example, produces different integration than standard bolus injection, as an infraorbital technique study demonstrates. Your provider should describe their approach in plain language.

• "Are you combining products or treatments, and what does the evidence say about that combination?" Hybrid CaHA-HA combinations appear in some rejuvenation contexts, and published clinical work documents their rationale. Combinations aren't inherently better—they require a provider who understands the interaction between agents.

• "What are the realistic risks for someone with my skin type and medical history?" A comprehensive review of minimally invasive facial techniques identifies vascular complications and product migration as documented risks across filler categories, per this clinical review. Any provider who skips this conversation skips an essential part of informed consent.

Short answers to these questions are a warning sign. Long, specific ones are what you're paying for.

---

This content is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. Consult a qualified, licensed healthcare professional before pursuing any aesthetic procedure.

What does recent research say about filler safety and satisfaction?

Recent clinical research shows that dermal fillers — across several formulations — deliver measurable, lasting improvements in wrinkles, volume loss, and skin quality, with satisfaction rates that hold up at six months and beyond. Researchers now compare filler types head-to-head, not just filler versus no treatment.

Hyaluronic acid fillers: what the comparisons show

A randomized, double-blind controlled trial pitting monophasic against biphasic hyaluronic acid (HA) fillers for moderate-to-severe nasolabial folds found both types corrected folds effectively, with no statistically significant difference in safety profiles between them. This tells consumers something important: the filler architecture — how the gel is manufactured — may matter less than the injector's technique and the product's rheological properties for a given treatment area.

Under-eye hollows: a technically demanding zone

The infraorbital area ranks among the hardest regions to treat. Two recent studies approached it from different angles:

• A pilot study on a composite collagen–crosslinked HA filler for under-eye rejuvenation reported clinically meaningful volume restoration with an acceptable safety profile in a controlled evaluation.
• The "BB8" injection technique using diluted Belotero Balance in the tear trough demonstrated that delivery method — not just product choice — shapes outcomes in this sensitive zone.

Skin quality, not just volume

Fillers do more than fill. A six-month observational study using low-cross-linked HA found measurable improvements in periorbital and perioral wrinkles and broader skin quality metrics — texture, hydration — that persisted across the full follow-up period. Results lasted. Patients noticed.

Beyond the face

Research is expanding into body applications. A study on hybrid calcium hydroxylapatite with HA filler for labia majora rejuvenation reported increased patient satisfaction and more uniform results compared to surgical labiaplasty alone — a finding that signals growing clinical interest in filler use outside traditional facial indications.

Biostimulatory and alternative fillers

Not all fillers work by adding volume directly. A comparative study on polydioxanone microsphere fillers for nasolabial fold correction used quantitative assessment tools to measure outcomes, reflecting a broader push in the field toward objective, measurable endpoints rather than subjective impression. A comprehensive review of minimally invasive facial rejuvenation techniques confirms that the evidence base for fillers continues to grow in rigor and scope.

---

This content is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. Consult a qualified, licensed healthcare provider before pursuing any cosmetic or aesthetic procedure.

FAQ

What is the difference between monophasic and biphasic hyaluronic acid fillers?

Monophasic HA fillers are manufactured as a single uniform gel, while biphasic fillers contain HA particles suspended in a gel carrier. A randomized controlled study (PMID 42528867) compared both types for nasolabial fold correction and found both effective, though their physical properties differ in ways that can influence how a provider chooses between them. A qualified injector can explain which formulation may suit your anatomy and goals.

Can calcium hydroxylapatite be used outside the face?

Yes. Research published in Aesthetic Surgery Journal Open Forum (PMID 42529489) describes the use of a hybrid CaHA-HA filler for labia majora rejuvenation, reporting increased patient satisfaction. Separately, a pilot study (PMID 42434377) investigated hyperdiluted CaHA combined with fractional microneedling radiofrequency for stretch marks (striae distensae). These are specialized applications that require a provider experienced in the relevant anatomy.

What makes the under-eye area particularly challenging for filler treatment?

The infraorbital (under-eye) region has thin skin, proximity to important structures, and a tendency to show the Tyndall effect—a bluish discoloration—if filler is placed too superficially. Studies on both a collagen-crosslinked HA composite (PMID 42448833) and a diluted HA technique called the BB8 method (PMID 42488280) highlight the importance of product selection and injection technique in this delicate zone.

How long do filler results typically last?

Duration varies by filler type, treatment area, individual metabolism, and lifestyle factors. A six-month observational study of low-cross-linked HA for periorbital and perioral wrinkles (PMID 42487104) documented measurable improvements in skin quality over that period. Longevity claims differ across products and are not guaranteed for any individual. Discuss realistic timelines with your provider.

What are PDO microsphere fillers and are they proven?

Polydioxanone (PDO) microsphere fillers are a newer category that use the same bioabsorbable material found in surgical sutures. A comparative study published in In Vivo (PMID 42379760) used quantitative imaging to assess PDO microsphere fillers against established options for nasolabial fold correction. Research is ongoing, and consumers should ask providers about the evidence base for any newer filler before proceeding.

Is there a single 'safest' filler for everyone?

No single filler is universally safest or most effective for all people and all areas. A comprehensive review of minimally invasive facial rejuvenation techniques (PMID 42441192) emphasizes that outcomes depend on product properties, injection technique, provider skill, and patient-specific factors. Always consult a licensed, experienced healthcare professional to evaluate your individual situation.

This article is for general information and is not medical advice. Aesthetic treatment results vary by individual -- consult a licensed, qualified provider before pursuing any cosmetic procedure.